Major Ingredients

Sitagliptin INN 50mg Tablet.

Major Functionality

Sitagliptin is indicated for the treatment of patients suffering from type-II diabetes mellitus. It is also used in combination with metformin or other glycemic control drugs.

Manufacture Information

Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.